Scott D. Grimes - 05 Aug 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
05 Aug 2022
Net transactions value
-$140,614
Form type
4
Filing time
08 Aug 2022, 16:38:18 UTC
Previous filing
20 Jul 2022
Next filing
03 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $140,614 -9,257 -3.7% $15.19 238,594 05 Aug 2022 Direct F1, F2, F3
holding CDLX Common Stock 55,832 05 Aug 2022 See Footnote F4
holding CDLX Common Stock 53,112 05 Aug 2022 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on June 9, 2022.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.87 to $15.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) to this Form 4.
F3 Includes 291 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.
F4 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F5 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.